Antonio Giordani Selected Research

Antonio Giordani Research Topics

4	Hyperalgesia 02/2016 - 08/2008
2	Arthritis (Polyarthritis) 01/2021 - 01/2009
2	Inflammation (Inflammations) 01/2021 - 05/2013
2	Edema (Dropsy) 01/2014 - 08/2008
1	Cystic Fibrosis (Mucoviscidosis) 01/2021
1	Neuroblastoma 01/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017
1	Non-alcoholic Fatty Liver Disease 01/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2013
1	Neuralgia (Stump Neuralgia) 01/2011
1	Pain (Aches) 01/2011
1	Brain Diseases (Brain Disorder) 01/2010
1	Disease Progression 01/2009

2	Riluzole FDA LinkGeneric 01/2017 - 01/2010
2	CarrageenanIBA 02/2016 - 08/2008
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2017
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	Oxygen (Dioxygen)IBA 01/2017
1	Silybin (Lagosa)IBA 01/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2014
1	2- methyl- 5- (4- methylsulphonyl)phenyl- 1- phenyl- 3- (2- n- propyloxyethyl)- 1H- pyrroleIBA 05/2013
1	VA428IBA 05/2013
1	Opioid Analgesics (Opioids)IBA 01/2011
1	CR4056IBA 01/2011
1	Freund's AdjuvantIBA 01/2011
1	Capsaicin (Zostrix)FDA Link 01/2011
1	LigandsIBA 01/2011
1	Analgesics (Analgesic Drugs)IBA 01/2011
1	Guanidine (Guanidine Nitrate)FDA Link 01/2010
1	ThioureaIBA 01/2010
1	Neuroprotective AgentsIBA 01/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2009
1	Matrix Metalloproteinases (MMPs)IBA 01/2009

1	Oral Administration 01/2011
1	Therapeutics 01/2009